Nicholas J Goulden
Overview
Explore the profile of Nicholas J Goulden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sidhu J, Masurekar A, Gogoi M, Fong C, Ioannou T, Lodhi T, et al.
Br J Haematol
. 2022 Mar;
198(1):142-150.
PMID: 35348200
In successive UK clinical trials (UKALL 2003, UKALL 2011) for paediatric acute lymphoblastic leukaemia (ALL), polyethylene glycol-conjugated E. coli L-asparaginase (PEG-EcASNase) 1000 iu/m was administered intramuscularly with risk-stratified treatment. In...
2.
Masurekar A, Parker C, Shanyinde M, Moorman A, Hancock J, Sutton R, et al.
PLoS One
. 2014 Oct;
9(10):e108107.
PMID: 25279465
Unlabelled: The outcomes of Central Nervous System (CNS) relapses in children with acute lymphoblastic leukaemia (ALL) treated in the ALL R3 trial, between January 2003 and March 2011 were analysed....
3.
Blair A, Goulden N, Libri N, Oakhill A, Pamphilon D
Blood Rev
. 2005 Nov;
19(6):289-300.
PMID: 16275419
Acute lymphoblastic leukaemia (ALL) responds well to chemotherapy and the majority of children and a significant proportion of adults are cured of their disease after primary therapy. However, a number...
4.
Cox C, Evely R, Oakhill A, Pamphilon D, Goulden N, Blair A
Blood
. 2004 Jul;
104(9):2919-25.
PMID: 15242869
Only some acute lymphoblastic leukemia (ALL) cells are thought to be capable of proliferating to maintain the leukemic clone, and these cells may be the most relevant to target with...
5.
Ronghe M, Halsey C, Goulden N
Paediatr Drugs
. 2003 Dec;
5(12):803-20.
PMID: 14658922
Thromboembolic disease (TED) is increasingly recognized as a major cause of morbidity and mortality in tertiary pediatrics. Children younger than 1 year of age and teenage girls are at greatest...